Diabetes Clinical Decision Support

Part of paid clinical trials in Hershey, Pennsylvania.

Sponsor
Milton S. Hershey Medical Center
Study ID
NCT05447806
Status
Recruiting
Apply to this trial

Conditions

  • Diabetes
  • Hyperglycemia
  • Hyperglycemia Stress
  • Hypoglycemia
  • PreDiabetes

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Active Electronic Medical Record Inpatient Diabetes Clinical Decision Support — DEVICE
    This prospective intervention will be carried out over 36 months and encompass 12 alternating GlucAlert-CDS phases lasting 3 months each. Six active phases (ON period) and six inactive phases (OFF period) will represent 18 months of intervention and control respectively. GlucAlert-CDS recognizes gaps in care denoting the automatic process of subjects' identification and inclusion. During the ON period, gap in care events detected in patients' EMR will evoke alert messages and care recommendations for clinicians in real time for their consideration. These notifications are programmed to be delivered to primary inpatient providers in direct care of these hospitalized patients. During the OFF period, the program will record the gaps in care events detected, but alerts will be inactive for providers' viewing.

Study Details

The purpose of this study is to determine the impact of an electronic medical record clinical decision support tool on rates of dysglycemia in the hospital, and its clinical and economical outcomes. The study also evaluates the perspectives of providers regarding the tool's usefulness on disease management support, knowledge, and practice performance.

Key Dates

Start date
Jul 15, 2022
Status verified
Aug 2025
Primary completion
Oct 16, 2025
Completion
Oct 16, 2026

Study Design

Enrollment
15,732 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Active Inpatient Diabetes Clinical Decision Support
    The Active arm consists of participants treated during the "ON" phase of the GlucAlert-CDS tool. The tool operates through an automated process of rules embedded in the EMR recognizing hypoglycemia (established or impending); recurrent hyperglycemia (in type 1 and 2 DM, or stress hyperglycemia-SH); and inappropriate insulin use (sliding scales monotherapy if recurrent hyperglycemia in type 2 DM or SH, or any time in type 1 DM). If the tool's criteria are met, an alert in the EMR will notify the provider with the clinically recommended treatment.
  • No Intervention: Inactive Inpatient Diabetes Clinical Decision Support
    The Inactive arm consists of participants treated during the "OFF" phase of the GlucAlert-CDS Tool. Alerts will not be sent to provider's

Primary Outcome Measure

Average hospital length of stay (LOS) [ Time Frame: Duration of hospital admission, up to 3 months ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Penn State Hershey Medical CenterHersheyPennsylvania17033
Ariana Pichardo-Lowden, MD
[email protected]
717-531-0003
Penn State Health St. Joseph Medical CenterReadingPennsylvania19605
Franciss Quigley, MD
[email protected]
610 378 2440

Find similar trials in Hershey, PA

By research site
Penn State Hershey Medical Center· Hershey, PAPenn State Health St. Joseph Medical Center· Reading, PA

Related Studies